152 related articles for article (PubMed ID: 28691147)
1. Gastric bypass simultaneously improves adipose tissue function and insulin-dependent type 2 diabetes mellitus.
Billeter AT; Vittas S; Israel B; Scheurlen KM; Hidmark A; Fleming TH; Kopf S; Büchler MW; Müller-Stich BP
Langenbecks Arch Surg; 2017 Sep; 402(6):901-910. PubMed ID: 28691147
[TBL] [Abstract][Full Text] [Related]
2. Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery.
Navaneethan SD; Kelly KR; Sabbagh F; Schauer PR; Kirwan JP; Kashyap SR
Obes Surg; 2010 Mar; 20(3):308-15. PubMed ID: 20217955
[TBL] [Abstract][Full Text] [Related]
3. Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass.
Lin E; Davis SS; Srinivasan J; Sweeney JF; Ziegler TR; Phillips L; Gletsu-Miller N
Am Surg; 2009 Jun; 75(6):498-502; discussion 502-3. PubMed ID: 19545098
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Effect of Foregut Exclusion Demonstrated by the Impact of Gastrogastric Fistula on Recurrence of Diabetes.
Jirapinyo P; Thompson AC; Kröner PT; Chan WW; Thompson CC
J Am Coll Surg; 2018 Mar; 226(3):259-266.e1. PubMed ID: 29274838
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation marker sCD163 is associated with liver injury and hepatic insulin resistance in obese patients before and after Roux-en-Y gastric bypass.
Kazankov K; Bojsen-Møller KN; Møller HJ; Madsbad S; Grønbaek H
Physiol Rep; 2022 Jan; 10(2):e15157. PubMed ID: 35040267
[TBL] [Abstract][Full Text] [Related]
6. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients.
Huang H; Kasumov T; Gatmaitan P; Heneghan HM; Kashyap SR; Schauer PR; Brethauer SA; Kirwan JP
Obesity (Silver Spring); 2011 Nov; 19(11):2235-40. PubMed ID: 21546935
[TBL] [Abstract][Full Text] [Related]
7. Reduction of oxidative stress on DNA and RNA in obese patients after Roux-en-Y gastric bypass surgery-An observational cohort study of changes in urinary markers.
Carlsson ER; Fenger M; Henriksen T; Kjaer LK; Worm D; Hansen DL; Madsbad S; Poulsen HE
PLoS One; 2020; 15(12):e0243918. PubMed ID: 33315915
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Impact of Body Fat Percentage Independent of Body Mass Index in Women with Obesity Remission After Gastric Bypass.
Eriksson Hogling D; Bäckdahl J; Thorell A; Rydén M; Andersson DP
Obes Surg; 2020 Mar; 30(3):1086-1092. PubMed ID: 31832934
[TBL] [Abstract][Full Text] [Related]
9. Association Between Dietary Intake After Roux-en-Y Gastric Bypass Surgery and Antioxidant/inflammatory Status: A 6-Month Pilot Prospective Cohort Study.
Hatami M; Haghighat N; Sohrabi Z; Javanbakht MH; Pazouki A; Farsani GM
Obes Surg; 2024 Jun; ():. PubMed ID: 38848028
[TBL] [Abstract][Full Text] [Related]
10. Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities.
SantaCruz-Calvo S; Bharath L; Pugh G; SantaCruz-Calvo L; Lenin RR; Lutshumba J; Liu R; Bachstetter AD; Zhu B; Nikolajczyk BS
Nat Rev Endocrinol; 2022 Jan; 18(1):23-42. PubMed ID: 34703027
[TBL] [Abstract][Full Text] [Related]
11. Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function.
Lamb RE; Goldstein BJ
Int J Clin Pract; 2008 Jul; 62(7):1087-95. PubMed ID: 18489578
[TBL] [Abstract][Full Text] [Related]
12. Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies.
Banerjee A; Singh J
Bioeng Transl Med; 2020 May; 5(2):e10150. PubMed ID: 32440558
[TBL] [Abstract][Full Text] [Related]
13. Adipokines and insulin action: A sensitive issue.
Knights AJ; Funnell AP; Pearson RC; Crossley M; Bell-Anderson KS
Adipocyte; 2014 Apr; 3(2):88-96. PubMed ID: 24719781
[TBL] [Abstract][Full Text] [Related]
14. Screening and validation of differentially expressed genes in adipose tissue of patients with obesity and type 2 diabetes mellitus.
Tong X; Liu C; Liang M; Ye X; Deng Z; Zhang X
Biomol Biomed; 2024 Jan; 24(1):40-50. PubMed ID: 37597213
[TBL] [Abstract][Full Text] [Related]
15. Neurological and metabolic related pathophysiologies and treatment of comorbid diabetes with depression.
Li S; Yang D; Zhou X; Chen L; Liu L; Lin R; Li X; Liu Y; Qiu H; Cao H; Liu J; Cheng Q
CNS Neurosci Ther; 2024 Apr; 30(4):e14497. PubMed ID: 37927197
[TBL] [Abstract][Full Text] [Related]
16. Role of obesity related inflammation in pathogenesis of peripheral artery disease in patients of type 2 diabetes mellitus.
Yadav U; Kumar N; Sarvottam K
J Diabetes Metab Disord; 2023 Jun; 22(1):175-188. PubMed ID: 37255816
[TBL] [Abstract][Full Text] [Related]
17. The oxidative aging model integrated various risk factors in type 2 diabetes mellitus at system level.
Chen Y; Yao L; Zhao S; Xu M; Ren S; Xie L; Liu L; Wang Y
Front Endocrinol (Lausanne); 2023; 14():1196293. PubMed ID: 37293508
[TBL] [Abstract][Full Text] [Related]
18. Leptin pathway is a crucial target for anthocyanins to protect against metabolic syndrome.
Liu M; Li S; Guan M; Bai S; Bai W; Jiang X
Crit Rev Food Sci Nutr; 2024 Apr; ():1-16. PubMed ID: 38567995
[TBL] [Abstract][Full Text] [Related]
19. Effect of Physical activity on Insulin Resistance, Inflammation and Oxidative Stress in Diabetes Mellitus.
Venkatasamy VV; Pericherla S; Manthuruthil S; Mishra S; Hanno R
J Clin Diagn Res; 2013 Aug; 7(8):1764-6. PubMed ID: 24086908
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
